[go: up one dir, main page]

Chang et al., 2020 - Google Patents

HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor

Chang et al., 2020

View PDF @Full View
Document ID
6265116580405767543
Author
Chang H
Shin Y
Keam B
Kim M
Im S
Lee S
Publication year
Publication venue
Annals of Clinical and Translational Neurology

External Links

Snippet

Objective While immune checkpoint inhibitors are increasingly used for various cancers, unpredictable immune‐related adverse events (irAEs) such as autoimmune encephalitis is life‐threatening. Here, we report an association between human leukocyte antigen (HLA) …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data

Similar Documents

Publication Publication Date Title
Chang et al. HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor
Jing et al. Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
Amstutz et al. Recommendations for HLA‐B* 15: 02 and HLA‐A* 31: 01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions
Boige et al. DPYD genotyping to predict adverse events following treatment with fluorouracil-based adjuvant chemotherapy in patients with stage III colon cancer: a secondary analysis of the PETACC-8 randomized clinical trial
Di Meglio et al. Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy
Walker et al. Personalized medicine approaches in epilepsy
Lin et al. A patch testing and cross‐sensitivity study of carbamazepine‐induced severe cutaneous adverse drug reactions
Hewett et al. Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
Leckband et al. Clinical Pharmacogenetics Implementation Consortium guidelines for HLA‐B genotype and carbamazepine dosing
Friedman et al. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review
Kolb et al. Neuromuscular complications of immune checkpoint inhibitor therapy
Watters et al. Genome-wide discovery of loci influencing chemotherapy cytotoxicity
Moon et al. The HLA‐A* 2402/C w* 0102 haplotype is associated with lamotrigine‐induced maculopapular eruption in the K orean population
Johnson et al. Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma
Trivedi et al. Alterations in DNA methylation status associated with gulf war illness
Haider et al. Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease
Liu et al. Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study
Gordon-Lipkin et al. An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future
Mahmoudpour et al. Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
Szoeke et al. Multidrug‐resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts
Petersen et al. Altered immune phenotype and DNA methylation in panic disorder
Özkan et al. Geriatric predictors of response and adverse events in older patients with cancer treated with immune checkpoint inhibitors: a systematic review
Asadi‐Pooya et al. Potential role of FKBP5 single‐nucleotide polymorphisms in functional seizures
Wong et al. HLA‐B* 15: 11 status and carbamazepine‐induced severe cutaneous adverse drug reactions in HLA‐B* 15: 02 negative Chinese
Mortazavi et al. Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population